Document Detail


Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease.
MedLine Citation:
PMID:  20847403     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Impaired glucose regulation is a defining characteristic of type 2 diabetes mellitus (T2DM) pathology and has been linked to increased risk of cognitive impairment and dementia. Although the benefits of aerobic exercise for physical health are well-documented, exercise effects on cognition have not been examined for older adults with poor glucose regulation associated with prediabetes and early T2DM. Using a randomized controlled design, twenty-eight adults (57-83 y old) meeting 2-h tolerance test criteria for glucose intolerance completed 6 months of aerobic exercise or stretching, which served as the control. The primary cognitive outcomes included measures of executive function (Trails B, Task Switching, Stroop, Self-ordered Pointing Test, and Verbal Fluency). Other outcomes included memory performance (Story Recall, List Learning), measures of cardiorespiratory fitness obtained via maximal-graded exercise treadmill test, glucose disposal during hyperinsulinemic-euglycemic clamp, body fat, and fasting plasma levels of insulin, cortisol, brain-derived neurotrophic factor, insulin-like growth factor-1, amyloid-β (Aβ40 and Aβ42). Six months of aerobic exercise improved executive function (MANCOVA, p=0.04), cardiorespiratory fitness (MANOVA, p=0.03), and insulin sensitivity (p=0.05). Across all subjects, 6-month changes in cardiorespiratory fitness and insulin sensitivity were positively correlated (p=0.01). For Aβ42, plasma levels tended to decrease for the aerobic group relative to controls (p=0.07). The results of our study using rigorous controlled methodology suggest a cognition-enhancing effect of aerobic exercise for older glucose intolerant adults. Although replication in a larger sample is needed, our findings potentially have important therapeutic implications for a growing number of adults at increased risk of cognitive decline.
Authors:
Laura D Baker; Laura L Frank; Karen Foster-Schubert; Pattie S Green; Charles W Wilkinson; Anne McTiernan; Brenna A Cholerton; Stephen R Plymate; Mark A Fishel; G Stennis Watson; Glen E Duncan; Pankaj D Mehta; Suzanne Craft
Related Documents :
7900783 - Effect of endurance training on hepatic glycogenolysis and gluconeogenesis during prolo...
10418073 - Exercise and the treatment of type 2 diabetes mellitus. an update.
2933383 - Effects of training on biochemical and functional properties of rodent neonatal heart.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Journal of Alzheimer's disease : JAD     Volume:  22     ISSN:  1875-8908     ISO Abbreviation:  J. Alzheimers Dis.     Publication Date:  2010  
Date Detail:
Created Date:  2010-11-18     Completed Date:  2011-03-09     Revised Date:  2014-09-08    
Medline Journal Info:
Nlm Unique ID:  9814863     Medline TA:  J Alzheimers Dis     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  569-79     Citation Subset:  IM    
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00220441
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Alzheimer Disease / etiology*
Amyloid beta-Peptides / blood
Brain-Derived Neurotrophic Factor / blood
Cognition Disorders / etiology*,  rehabilitation*
Executive Function / physiology
Exercise*
Exercise Therapy / methods*
Female
Follow-Up Studies
Glucose Clamp Technique / methods
Glucose Intolerance / complications*,  rehabilitation
Heart Rate / physiology
Humans
Insulin-Like Growth Factor I / metabolism
Male
Memory / physiology
Middle Aged
Neuropsychological Tests
Oxygen Consumption / physiology
Risk Factors
Grant Support
ID/Acronym/Agency:
KL2 RR025015/RR/NCRR NIH HHS; KL2 RR025015-03/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Amyloid beta-Peptides; 0/Brain-Derived Neurotrophic Factor; 67763-96-6/Insulin-Like Growth Factor I
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Functional representation of olfactory impairment in early Alzheimer's disease.
Next Document:  Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimer's disease.